Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Fate Therapeutics · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
adultimmune-checkpoint-inhibitormerkel-cell-carcinomank-cellsnon-small-cell-lung-cancernsclcrenal-cell-carcinomasolid-tumor
This is a Phase 1 dose-finding study of FT-516 in combination with monoclonal antibodies in participants with advanced solid tumors. The study will consist of a dose-escalation stage and an expansion stage where participants will be enrolled into indication-specific cohorts.
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 872147
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive